In addition to major pathways, such as complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity, some functional antibodies exhibit remarkable therapeutic effectiveness by modulating specific signaling cascades such as the vascular endothelial growth factor (VEGF) pathway during tumor angiogenesis [2]. The gene discussed is VEGFA; the disease is neoplasm.